These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
101 related items for PubMed ID: 682365
61. [Plasma level of dibekacin in children with mucoviscidosis. Comparison with a control population]. Loeuille GA, Cournol R, Delnatte J, Martin G. Ann Pediatr (Paris); 1987 Nov; 34(9):713-7. PubMed ID: 3426082 [No Abstract] [Full Text] [Related]
62. [Therapeutic experience with 3',4'-dideoxykanamycin B (DKB) (author's transl)]. Yamagishi M, Kojima K. Jpn J Antibiot; 1974 Aug; 27(4):549-55. PubMed ID: 4436960 [No Abstract] [Full Text] [Related]
63. Disposition of Dibekacin in patients undergoing haemodialysis. Campillo JA, Lanao JM, Dominguez-Gil A, Rubio F, Martin A. Eur J Clin Pharmacol; 1980 Oct; 18(4):347-50. PubMed ID: 7439256 [Abstract] [Full Text] [Related]
64. Morphological analysis of transportation pathways of microspheres after their introduction into the uterine horn cavity in cyclic pigs. Doboszyńska T, Andronowska A. Cell Tissue Res; 2004 Jul; 317(1):91-9. PubMed ID: 15179588 [Abstract] [Full Text] [Related]
66. Temporal changes in proteins of oviduct and uterine fluids during the preimplantation period in the rabbit. Tucker EB, Schultz A. Biol Reprod; 1977 Dec; 17(5):749-59. PubMed ID: 597542 [No Abstract] [Full Text] [Related]
67. Pharmacodynamics and pharmacokinetics of dibekacin in the neonate--comparison between the intramuscular and intravenous routes. Autret E, Borderon JC, Saliba E, Koki P, Ployet MJ, Gold F, Breteau M, Laugier J. Dev Pharmacol Ther; 1984 Dec; 7 Suppl 1():121-4. PubMed ID: 6518951 [No Abstract] [Full Text] [Related]
68. [Diffusion of amikacin in the lungs]. Saux MC, Crockett R, Fourtillan JB, Leng B, Couraud L. Pathol Biol (Paris); 1986 Feb; 34(2):113-7. PubMed ID: 3517776 [Abstract] [Full Text] [Related]
69. Absorption of proinflammatory cytokines from inflamed porcine uterus into the uterine venous blood--preliminary data. Kucharski J, Stefańczyk-Krzymowska S, Jana B. Pol J Vet Sci; 2008 Feb; 11(1):9-16. PubMed ID: 18540202 [Abstract] [Full Text] [Related]
70. Differential regulation of a low-molecular-weight protein in oviductal and uterine fluids by ovarian hormones. Goswami A, Feigelson M. Endocrinology; 1974 Sep; 95(3):669-75. PubMed ID: 4851387 [No Abstract] [Full Text] [Related]
71. Efficacy of an antibiotic coated indwelling catheter: a preliminary report. Sakamoto I, Umemura Y, Nakano H, Nihira H, Kitano T. J Biomed Mater Res; 1985 Sep; 19(9):1031-41. PubMed ID: 3910651 [Abstract] [Full Text] [Related]
72. [Serum concentrations and clinical efficacy of dibekacin after intravenous drip infusion to patients with respiratory tract infections]. Soejima R, Niki Y, Matsushima T, Tano Y. Jpn J Antibiot; 1982 Dec; 35(12):2773-7. PubMed ID: 7182533 [No Abstract] [Full Text] [Related]
73. Interaction of 3',4'-dideoxykanamycin B and submaxillary mucin. Aramaki Y, Niibuchi J, Tsuchiya S, Hosoda J. Chem Pharm Bull (Tokyo); 1987 Jan; 35(1):320-5. PubMed ID: 3594663 [No Abstract] [Full Text] [Related]
78. [Protective effect of fosfomycin against aminoglycoside induced ototoxicity]. Ohtsuki K, Ohtani I, Aikawa T, Sato Y, Anzai T, Ouchi J, Saito T. Nihon Jibiinkoka Gakkai Kaiho; 1983 Dec; 86(12):1487-96. PubMed ID: 6674446 [No Abstract] [Full Text] [Related]
79. A comparative study on the ototoxicity of dibekacin and tobramycin administered by intravenous infusion. Ohtani I, Ohtsuki K, Aikawa T, Ouchi J, Nakayoshi T. Jpn J Antibiot; 1979 Oct; 32(10):990-7. PubMed ID: 513289 [No Abstract] [Full Text] [Related]
80. [Inhibitory effect of nasal mucus on the absorption of drugs through respiratory epithelium]. Hayashi H. Nihon Jibiinkoka Gakkai Kaiho; 1990 Jan; 93(1):40-9. PubMed ID: 2319385 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]